Quell Therapeutics pulls in funding
UK-based Quell Therapeutics, a new cell therapy company, has secured 35 million pounds in funding. Syncona was the lead investor with participation from UCL Technology Fund.
20 May 2019•5 mins read
UK-based Quell Therapeutics, a new cell therapy company, has secured 35 million pounds in funding. Syncona was the lead investor with participation from UCL Technology Fund.
